The nuclear corepressors NCoR and SMRT are key regulators of both ligand- and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor

Molecular and Cellular Biology

Volumn 18, Issue 3, 1998, Pages 1369-1378

  Wagner, Brandee L ^a   Norris, John D ^a   Knotts, Trina A ^b   Weigel, Nancy L ^b   Mcdonnell, Donald P ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 BROMO CYCLIC AMP; PROGESTERONE RECEPTOR; RETINOID; THYROID HORMONE RECEPTOR;

ARTICLE; BINDING AFFINITY; MAMMAL; PRIORITY JOURNAL; PROTEIN CONFORMATION; RECEPTOR BINDING; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

EID: 0031910827     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.3.1369     Document Type: Article

References (46)

1. Allan, G. F., X. Leng, S.-T. Tsai, N. L. Weigel, D. P. Edwards, M.-J. Tsai, and B. W. O'Malley. 1992. Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation. J. Biol. Chem. 267:19513-19520.
2. Allan, G. F., E. Lombardi, D. Haynes-Johnson, S. Palmer, M. Kiddoe, P. Kraft, C. Campen, P. Rybczynski, D. W. Combs, and A. Phillips. 1996. Induction of a novel conformation in the progesterone receptor by ZK299 involves a defined region of the carboxyl-terminal tail. Mol. Endocrinol. 10:1206-1213.
3. Baniahmad, A., A. C. Köhne, and R. Renkawitz. 1992. A transferable silencing domain is present in the thyroid hormone receptor, in the v-erbA oncogene product and in the retinoic acid receptor. EMBO J. 11:1015-1023.
4. Baniahmad, A., C. Steiner, A. C. Kohne, and R. Renkawitz. 1990. Molecular structure of a chicken lysozyme silencer: involvement of an unusual thyroid hormone receptor binding site. EMBO J. 61:505-514.
5. Beck, C. A., N. L. Weigel, and D. P. Edwards. 1992. Effects of hormone and cellular modulators of protein phosphorylation on transcriptional activity, DNA binding, and phosphorylation of human progesterone receptors. Mol. Endocrinol. 6:607-620.
6. Beck, C. A., N. L. Weigel, M. L. Moyer, S. K. Nordeen, and D. P. Edwards. 1993. The progesterone antagonist RU486 acquires agonist activity upon stimulation of cAMP signaling pathways. Proc. Natl. Acad. Sci. USA 90:4441-4445.
7. Berry, M., D. Metzgar, and P. Chambon. 1990. Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J. 9:2811-2818.
8. Brent, G. A., M. K. Dunn, J. W. Harney, T. Gulick, P. R. Larsen, and D. D. Moore. 1989. Thyroid hormone aporeceptor represses T3-inducihle promoters and blocks activity of the retinoic acid receptor. New Biol. 1:329-336.
9. Chen, J. D., and R. M. Evans. 1995. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454-457.
10. Chen, J. D., K. Umesono, and R. M. Evans. 1996. SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers. Proc. Natl. Acad. Sci. USA 93:7567-7571.
11. Cohen, L. A., and P. Chan. 1974. Intracellular cAMP levels in normal rat mammary gland and adenocarcinoma: in vivo vs. in vitro. Life Sci. 16:107-115.
12. Damm, K., C. C. Thompson, and R. M. Evans. 1989. Protein encoded by v-erbA functions as a thyroid-hormone receptor antagonist. Nature 339:593-597.
13. Delabre, K.., A. Guiochon-Mantel, and E. Milgrom. 1993. In vivo evidence against the existence of antiprogestins disrupting receptor binding to DNA. Proc. Natl. Acad. Sci. USA 90:4421-4425.
14. Denner, L. A., N. L. Weigel, B. L. Maxwell, W. T. Schrader, and B. W. O'Malley. 1990. Regulation of progesterone receptor-mediated transcription by phosphorylation. Science 250:1740-1743.
15. Evans, R. M. 1988. The steroid and thyroid hormone receptor superfamily. Science 240:889-895.
16. Fujimoto, N., and B. S. Katzenellenbogen. 1994. Alteration in the agonist/antagonist balance of antiestrogens by activation of protein kinase A signaling pathways in breast cancer cells: anitestrogen selectivity and promoter dependence. Mol. Endocrinol. 8:296-304.
17. Horlein, A. J., A. M. Naar, T. Heinzel, J. Torchia, B. Gloss, R. Kurokawa, A. Ryan, Y. Kamei, M. Soderstrom, C. K. Glass, and M. G. Rosenfeld. 1995. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397-403.
18. Huggenvik, J. I., M. W. Collard, Y.-W. Kim, and R. P. Sharma. 1993. Modification of the retinoic acid signaling pathway by the catalytic subunit of protein kinase-a. Mol. Endocrinol. 7:543-550.
19. Ince, B. A., M. M. Montano, and B. S. Katzenellenbogen. 1994. Activation of transcriptionally inactive human estrogen receptors by cyclic adenosine 3′,5′-monophosphate and ligands including antiestrogens. Mol. Endocrinol. 8:1397-1406.
20. Ing, N., J. Beekman, S. Tsai, M.-J. Tsai, and B. O'Malley. 1992. Members of the steroid hormone receptor superfamily interact with TFIIB (S300-II). J. Biol. Chem. 267:17617-17623.
21. Jackson, T. A., J. K. Richer, D. L. Bain, G. S. Takimoto, L. Tung, and K. B. Horwitz. 1997. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR and SMRT. Mol. Endocrinol. 11:693-705.
22. Klein-Hitpass, L., A. C. B. Cato, D. Henderson, and G. U. Ryffel. 1991. Two types of antiprogestins identified by their differential activation in transcriptionally active extracts from T47D cells. Nucleic Acids Res. 19:1227-1234.
23. McDonnell, D. P. 1995. Unraveling the human progesterone receptor signal transduction pathway: insights into antiprogestin action. Trends Endocrinol. Metab. 6:133-138.
24. McDonnell, D. P., D. L. Clemm, T. Herman, M. E. Goldman, and J. W. Pike. 1995. Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Mol. Endocrinol. 9:659-669.
25. Meyer, M. E., A. Pornon, J. Ji, M. T. Bocquel, P. Chambon, and H. Gronemeyer. 1990. Agonist and antagonist properties of RU486 on the functions of the human progesterone receptor. EMBO J. 9:3923-3932.
26. Minion, J. P., T. Wisenbaugh, and R. Matthews. 1974. Elevated cyclic AMP levels in human breast-cancer. J. Natl. Cancer Inst. 53:283.
27. Nordeen, S., B. Bona, and M. Moyer. 1993. Latent agonist activity of the steroid antagonist, RU486, is unmasked in cells treated with activators of protein kinase A. Mol. Endocrinol. 7:731-742.
28. Norris, J., D. Fan, C. Aleman, J. R. Marks, A. Futreal, R. W. Wiseman, J. D. Iglehart, P. L. Deininger, and D. P. McDonnell. 1995. Identification of a new subclass of alu DNA repeats which can function as estrogen receptor-dependent transcriptional enhancers. J. Biol. Chem. 270:22777-22782.
29. Onate, S. A., S. Tsai, M.-J. Tsai, and B. W. O'Malley. 1995. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357.
30. Rangarajan, P. N., K. Umesono, and R. M. Evans. 1992. Modulation of glucocorticoid receptor function by protein kinase A. Mol. Endocrinol. 6:1451-1457.
31. Renaud, J.-P., N. Rochel, M. Ruff, V. Vivat, P. Chambon, H. Gronemeyer, and D. Moras. 1995. Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature 378:681-689.
32. Sartorius, C. A., L. Tung, G. S. Takimoto, and K. B. Horwitz. 1993. Antagonist-occupied human progesterone receptors bound to DNA are function-ally switched to transcriptional agonists by cAMP. J. Biol. Chem. 268:9262-9266.
33. Schreiber, E., P. Matthias, M. M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17:6419.
34. Smith, C. L., Z. Nawaz, and B. W. O'Malley. 1997. Coactivator and core-pressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen. Mol. Endocrinol. 11:657-666.
35. Smith, C. L., S. A. Onate, M.-J. Tsai, and B. W. O'Malley. 1996. CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription. Proc. Natl. Acad. Sci. USA 93:8884-8888.
36. Smith, D. F., B. A. Stensgard, W. J. Welch, and D. O. Toft. 1992. Assembly of progesterone receptor with heat shock proteins and receptor activation are ATP mediated events. J. Biol. Chem. 267:1350-1356.
37. Soderstrom, M., A. Vo, T. Heinzel, R. M. Lavinsky, W.-M. Yang, E. Seto, D. A. Peterson, M. G. Rosenfeld, and C. K. Glass. 1997. Differential effects of nuclear receptor corepressor (N-CoR) expression levels on retinoic acid receptor-mediated repression support the existence of dynamically regulated corepressor complexes. Mol. Endocrinol. 11:682-692.
38. Tzukerman, M. T., A. Esty, D. Santiso-Mere, P. Danielian, M. G. Parker, R. B. Stein, J. W. Pike, and D. P. McDonnell. 1994. Human estrogen receptor transcriptional capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol. Endocrinol. 8:21-30.
39. Vegeto, E., G. F. Allan, W. T. Schrader, M.-J. Tsai, D. P. McDonnell, and B. W. O'Malley. 1992. The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor. Cell 69:703-713.
40. Voegel, J. J., M. J. S. Heine, C. Zechel, P. Chambon, and H. Gronemeyer. 1996. TIF2, a 160kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J. 15:3667-3675.
41. Wagner, B. L., G. Pollio, S. Leonhardt, M. C. Wani, D. Y.-W. Lee, M. O. Imhof, D. P. Edwards, C. E. Cook, and D. P. McDonnell. 1996. 16α-substituted analogs of the antiprogestin RU486 induce a unique conformation in the human progesterone receptor resulting in mixed agonist activity. Proc Natl. Acad. Sci. USA 93:8739-8744.
42. Wagner, R. L., J. W. Apriletti, M. E. McGrath, B. L. West, J. D. Baxter, and R. J. Fletterick. 1995. A structural role for hormone in the thyroid hormone receptor. Nature 378:690-697.
43. Weigel, N. L. Unpublished data.
44. Xu, J., Z. Nawaz, S. Y. Tsai, M.-J. Tsai, and B. W. O'Malley. 1996. The extreme C terminus of progesterone receptor contains a transcriptional repressor domain that functions through a putative corcpressor. Proc. Natl. Acad. Sci. USA 93:12195-12199.
45. Zamir, I., J. Zhang, and M. A. Lazar. 1997. Stoichiometric and steric principles governing repression by nuclear hormone receptors. Genes Dev. 11:835-846.
46. Zhang, S., and M. Danielson. 1995. Selective effects of 8-br-cAMP on agonists and antagonists of the glucocorticoid receptor. Endocrine 3:5-12.